CDEK
← All organizations

Tillotts Pharma

For profitContributed to NME

Also known as: Tillotts Pharma AG

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2002

Last known activity

Nov 25, 2016

Acquired by Medeva → Celltech → UCB on Jan 1, 1995

Timeline

1950s

  1. Jan 1, 1955

    Tillotts Pharma— Founded

1990s

  1. Jan 1, 1995

    Medeva— Acquired By

2000s

  1. Jan 1, 2004

    UCB— Now

Drugs by trial phase (5 distinct, 12 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

Details

Founded
London, GB Jan 1, 1955
Last known activity
Nov 25, 2016